Craig A. Johnson is on the board of Heron Therapeutics, Inc., Tetraphase Pharmaceuticals, Inc., Mirati Therapeutics, Inc. and Odonate, Inc. In his past career Mr. Johnson was Chief Financial Officer at PURE Bioscience, Inc., Chief Financial Officer, Secretary & Senior VP at NovaDel Pharma, Inc., President of Philip Morris USA, Inc., Chief Financial Officer & Senior VP-Operations at MitoKor, Inc., Chief Financial Officer & Vice President at TorreyPines Therapeutics, Inc., Chief Financial Officer & Vice President at TPTX, Inc., Vice President of Raptor Pharmaceuticals Corp. and Vice President at Horizon Pharmaceutical LLC.

He received an undergraduate degree from The University of Michigan-Dearborn.